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Abstract
Background: Premature ovarian insufficiency is a common complication of anticancer treatments in young women
and girls. The ovary is a complex, highly regulated reproductive organ, whose proper function is contingent upon
the bidirectional endocrine, paracrine, and autocrine signaling. These factors facilitate the development of the
follicles, the functional units of the ovary, to progress from the gonadotropin-independent, paracrine-controlled
early stage to the gonadotropin-dependent, endocrine-controlled later stage. We hypothesized that the low survival
rate of individually cultured early-stage follicles could be improved with co-culture of adipose-derived stem cells
(ADSCs) that secrete survival- and growth-promoting factors.
Materials and methods: Ovarian follicles ranging from 85 to 115 μm in diameter, from 10- to 12-day-old B6CBAF1
mice were mechanically isolated and co-encapsulated with ADSCs within alginate-based 3D culture system. The
follicles were cultured for 14 days, imaged using light microscopy every 2 days, and matured at the end. Follicle
media were changed every 2 days and collected for hormone measurements. Follicle diameter, morphology,
number of transzonal projections, and survival and maturation rates were recorded. Statistical analyses using one-
and two-way ANOVA were performed to compare hormone levels, survival of the follicles and ADSCs, oocyte
maturation rates, and follicle growth.
Results: The co-encapsulation of the follicles with ADSCs increased follicle survival, ranging from 42.4% for the
86–95 μm to 86.2% for the 106–115-μm follicle size group. Co-culture also improved the follicle growth, the rate of
antrum formation and oocyte maturation compared to the follicles cultured alone. The levels of androstenedione,
estradiol, and progesterone of co-encapsulated follicles increased progressively with time in culture.
Conclusions: To our knowledge, this is the first report of an in vitro system utilizing mouse adipose-derived stem cells
to support the development of the mouse follicles. Our findings suggest that co-encapsulation of ADSCs with early-
stage follicles supports follicular development, through secretion of cytokines that promote follicular survival, antrum
formation, and meiotic competence. The unique 3D culture system that supports the survival of both cell types has
translational implications, as ADSCs could be used as an autologous source for in vitro maturation of early-stage
human follicles.
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Background
Medical science has advanced greatly in its potential to
treat various cancers, with some cancer therapies reach-
ing > 90% 5-year survival [1]. The success of these ther-
apies comes at the cost of future fertility and
reproductive function. Cancer survival now means facing
another challenge, consideration for quality of life after
treatment, which may occur at the cost of future fertility
and reproductive endocrine function. The preservation
of oocytes, sperm, gonadal tissue, or embryos before ini-
tiation of chemotherapy is the most common fertility
preservation options [2–5]. However, these options are
non-applicable or contraindicated in pre-pubertal pa-
tients with hematologic malignancies who are too young
to produce mature eggs or due to the concern of re-
introducing malignant cells after ovarian tissue auto-
transplantation [4, 6, 7]. The goal of providing broad
and inclusive fertility preservation options to these
young cancer survivors has fueled and shaped research
within the field of oncofertility [8–10]. Innovations in
stem cell differentiation and in vitro gamete culture are
showing great promise, and several large academic cen-
ters are cryopreserving gonadal tissue with the hope of
future scientific discovery [8–13].
The human ovary is a complex, highly regulated repro-
ductive organ, whose proper function is contingent upon
the vital local and systemic bidirectional signaling [14, 15].
The functional unit of the ovary is the follicle, which relies
on endocrine, paracrine, and autocrine factors to allow the
successful developmental progression of the follicles from
the gonadotropin-independent primary stage to the later
antral stages and peaks with the maturation of fertilizable
oocytes. Over the past 15 years, significant progress has
been made in creating culture systems that support pre-
ovulatory follicle development and the production of mei-
otically competent eggs that result in live birth in rodents
[16–22]. Three-dimensional (3D) hydrogel-based culture
systems help support the morphologic and functional en-
vironment of the follicular unit; allow bidirectional diffu-
sion of nutrients, hormones, and oxygen; and maintain
the spherical structural integrity, thus separating and
maintaining gradients of factors between cumulus and
mural granulosa cells, similar to that occurring in vivo.
One of the most studied materials for 3D follicle cul-
ture is seaweed-derived alginate [23–27]. Alginate is an
inert polysaccharide polymer that crosslinks at physio-
logical conditions and supports culture, survival, and
maturation of secondary follicles from different species
[16, 26, 28–30]. However, culture and maturation of
early-stage follicles from mice with an initial diameter
below 120 μm have long presented challenges for suc-
cessful folliculogenesis, survival, and maturation [31].
When cultured individually at this early stage, the folli-
cles show markedly decreased survival. Co-culture of
early-stage ovarian follicles with “feeder cells,” such as
embryonic fibroblasts, multiple ovarian follicles, or ovar-
ian stromal cells, have been found to significantly im-
prove the outcomes of follicular development within
these in vitro systems, possibly through the interactions of
multiple paracrine signals. However, limited sources of hu-
man embryonic fibroblasts or ovarian stromal cells, and
incompatibility of human follicles with mouse cells limit
the translation of this approach to patients [32, 33]. There-
fore, the accessibility, compatibility, and multipotent differ-
entiation potential of adipose-derived stem cells (ADSCs)
make them attractive candidates for human translational
studies and future therapeutic indications [34]. The use of
ADSCs and other types of mesenchymal stem cells has
been well studied for their paracrine-mediated therapeutic
effects on wound healing and regeneration [35–38]. Re-
cent reports of the use of mesenchymal stem cells for the
paracrine mediated, restoration of ovarian function in ani-
mal models of primary ovarian insufficiency [39–41] pro-
vide the basis for our hypothesis that the paracrine signals
from ADSCs can rescue individually cultured primary and
early secondary ovarian follicles and promote folliculogen-
esis [38]. We recently analyzed the secretome of hu-
man ADSCs cultured in three-dimensional culture and
found statistically significant increases in cytokine produc-
tion [36] and gene expression [38] among genes and cyto-
kines that have previously been established as vital to
follicular survival, growth, and development. Upregulated
genes included vascular endothelial growth factor A
(VEGFA), transforming growth factor-beta 2 (TGF-β2),
and hepatocyte growth factor (HGF), which are known to
be beneficial for follicular angiogenesis, follicular regula-
tion, and apoptotic suppression, respectively. Zhou et al.
demonstrated an increase in monocyte chemotactic
protein-1 (MCP-1) (related to oocyte maturation), Follis-
tatin (regulation of granulosa cell proliferation), and IL-6
(regulator of cumulus cell function) [36].
In this study, mouse ovarian follicles were
co-encapsulated with ADSCs in alginate hydrogels and
cultured for 14 days. Follicle survival, growth, and mat-
uration rates significantly improved in the presence of
ADSCs. To our knowledge, this is the first report of the
application of mouse ADSCs supporting in vitro ovarian
follicular development in a 3D co-culture setting. Re-
search in this direction could also be the basis for future
research into the secretome of ADSCs within in vitro
culture system to help us better understand
ADSC-derived secretory factors that play vital roles in
establishing optimal ovarian micro-environment for pro-
moting early stages of folliculogenesis.
Methods
Because ADSCs could provide a readily accessible, high
yield, autologous source for in vitro follicle culture of
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early-stage follicles, we investigated whether ADSCs
from the same species co-encapsulated with primary and
early secondary ovarian follicles in a 3D alginate hydro-
gel system would improve the outcomes of in vitro
folliculogenesis.
Source of adipose-derived stem cells
OriCell C57BL/6 Mouse ADSCs (Cyagen, Santa Clara,
CA, USA) were commercially acquired. The ADSCs were
isolated from the inguinal fat pads of pre-pubertal C57B6
female mice and cultured in monolayer for six passages
prior to the first use. The cells have previously tested posi-
tive for stem cell markers CD34, CD44, stem cells
antigen-1 (SCA-1), and negative for CD117 by flow cy-
tometry analysis. Upon procurement, the cells were
thawed and subsequently passaged for up to three pas-
sages using Cyagen ADSC growth media (includes basal
medium and growth supplement; Cyagen Biosciences Inc.,
Suzhou, Jiangsu, China) per manufacturer's instructions.
Lineage differentiation and characterization of ADSCs
To determine the multipotency of the ADSCs used in
the follicle co-culture, the cells were cultured in osteo-
genic, adipogenic, and chondrogenic media per the man-
ufacturer’s protocol (Cyagen). All cells were imaged
using light microscopy (Leica, DMI 3000, Germany).
ADSC surface marker expression
ADSCs were immuno-stained for surface marker ana-
lysis with fluorescence-conjugated anti-mouse antibodies
in accordance with the manufacturer’s instructions.
Briefly, cells at 7–8th original passages were grown in
monolayer until reaching 80–90% confluence. Cells were
then trypsinized with 0.25% trypsin-EDTA and washed
with FACS buffer (PBS and 2% BSA). Cell number was
determined using an automated cell counter Moxi
z-mini (Orflo Technologies, Ketchum, ID, USA). Cells
(2.0 × 105) were incubated with monoclonal antibodies
for 30 min on ice in the dark. Unstained cells were used
as a negative control. The following surface markers
were analyzed: CD45/Alexa Flour, CD34/BV421, CD90/
PE, CD31/APC, SCA-1/BB515, and CD44/BV570. Ten
thousand events per sample were obtained for each
marker, and sample analysis performed in duplicate. Data
were analyzed using FlowJo (LLC, Ashland, OR, USA).
Viability of ADSCs within the alginate hydrogel culture
system
To determine the survival of ADSCs within the culture
system and the effects of both culture media and ex-
ogenous hormones on cell viability, 5 × 105 ADSCs/ml
were suspended in alginate solution and encapsulated in
crosslinked alginate beads with and without the ovarian
follicles. Beads were removed at days 1, 4, 7, 10, and 14
of culture to test the viability, and the experiments were
repeated four times. Using the LIVE/DEAD assay (Ther-
mofisher, Eugene, OR, USA), alginate beads were incu-
bated with Calcein AM and ethidium homodimer-1 per
manufacturer’s protocol. Beads were then imaged with
light microscopy (DMI3000, Leica, Germany). Quantifi-
cation of the percentage of live and dead cells was per-
formed via an automated analysis using ImageJ software
(Rasband, W.S., ImageJ, National Institutes of Health,
Bethesda, MD, USA). Light microscopy, green, and red
filter images were obtained for each condition at each
time point. All images were converted to a binary image
in which cell pixels were black and the background was
white. The images were then analyzed for the number of
total cells, based on the light microscopy image, and the
number of green (live) and red (dead) fluorescing cells.
Follicle isolation, encapsulation, and culture
The ovaries were obtained from 10- to 12-day-old F1 hy-
brid mice (C57BL/6JRccHsd inbred ×CBA/J CrHsd,
Envigo, Indianapolis, IN, USA). The animals were bred
and housed in a light (12-h light/12-h darkness) and
temperature-regulated environment within ventilated
cages. All animal handling procedures were in accord-
ance with the regulations and guidelines by the National
Institutes of Health Guide for the Care and Use of La-
boratory Animals and approved by the Institutional Ani-
mal Use and Care protocol of the University of
Michigan. Primary and early secondary ovarian follicles
were mechanically isolated from the ovaries and encap-
sulated as previously described [41] with slight modifica-
tions. Briefly, for each experiment, primary and early
secondary follicles, ranging from 85 to 115 μm in diam-
eter, were mechanically isolated from 6 to 8 ovaries
using insulin gauge needles, while immersed in dissec-
tion media (Leibovitz’s L-15 medium/1% fetal bovine
serum/0.5% penicillin-streptomycin). Isolated follicles
from multiple mice were combined and stored in main-
tenance media (minimum essential media-alpha modifi-
cations (α-MEM) with GlutaMAX, 1% fetal bovine
serum, and 0.5% penicillin-streptomycin) in a CO2 incu-
bator for up to 2 h. Morphologically intact follicles ran-
ging from 85 to 115 μm in size were selected and
immersed in 0.25% alginate, with and without ADSCs.
Droplets (10 μl) of alginate with the enclosed follicle
(+/−ADSCs) were immersed in 50mM CaCl2 and 140
mM NaCl solution for 2 min to crosslink and form
beads. Alginate beads with encapsulated follicles with
and without ADSCs were then transferred to individual
wells of a 96-well plate, containing 100 μl of growth
media (α-MEM supplemented with 3 mg/mL bovine
serum albumin (BSA, MPBiomedicals, Irvine, CA, USA),
1 mg/mL bovine fetuin, 5 μg/mL insulin, 5 μg/mL trans-
ferrin, 5 ng/mL selenium (ITS, Sigma, St. Louis, MO,
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USA), and 10mIU/mL highly purified, human-derived,
follicle-stimulating hormone (FSH) (Urofollitropin, Fer-
ring Pharmaceuticals, Saint-Prex, Switzerland). The folli-
cles were cultured in either 0.25% alginate beads alone
or co-encapsulated in 0.25% alginate with ADSCs at a
concentration of 5 × 105 cells/ml at 37oC in 5% CO2 for
14 days. The ADSC concentration that maximized
follicle survival was determined empirically by
co-encapsulating follicles with ADSCs at concentrations
ranging from 1 × 105 to 8.0 × 105 cell/ml. Beginning on
day 6 of culture, half of the medium (50 μl) from each
well was replaced with fresh growth medium every 2 days
and the medium was stored at − 20 °C for a subsequent
measure of steroid hormone production.
Assessment of follicle survival and growth
Follicle viability was determined based on the absence of
morphological characteristics such as early oocyte extru-
sion, signs of atresia, or degeneration. To assess the
growth of the follicles, light microscopy images were
captured using an inverted Leica DM light microscope
(DMI 3000, Leica, Germany). An average diameter was
obtained by taking two perpendicular measurements of
surviving follicles using ImageJ software (National Insti-
tutes of Health).
Steroid hormone production by encapsulated follicles
The media from 3 to 4 follicles of the same initial follicle
diameter range and time points were pooled together to
achieve the requisite volume. Steroid hormone produc-
tion was measured in a total of 6 pooled samples per ex-
perimental condition for each follicular size category.
Concentrations of androstenedione (A4), 17β-estradiol
(E2), and progesterone (P4) in the collected media were
measured at the University of Virginia Center for Re-
search in Reproduction Ligand Assay and Analysis Core
(Specialized Cooperative Centers Program in
Reproduction Research). The sensitivity for A4 was 0.1
ng/mL, for estradiol 10 pg/ml, and for P4 0.1 ng/ml. The
coefficient of variation for A4 was 1.5% for ALPCO QC1
at the range 0.15–0.25 ng/ml, 2.6% for ALPCO QC2 at
the range 1.75–2.91 ng/ml, 1.0% for Bio-Rad 1 at the
range 0.42–0.72 ng/mL, 3.7% for Bio-Rad 2 at the range
0.96–1.78 ng/mL, and 1.1% for Bio-Rad 3 at the range
1.7–3.3 ng/mL. The coefficient of variation for E2 was
3.9% for Bio-Rad 1 at the range 58.0–108.0 pg/ml, 10.2%
for Bio-Rad 2 at the range 176.0–328.0 pg/mL, and 1.5%
for Bio-Rad 3 at the range 437.0–811.0 pg/mL. The coef-
ficient of variation for P4 was 13.7% for Rodent QC1 at
the range 8–15 ng/ml, 2.5% for Rodent QC2 at the range
2.6–4.8 ng/ml, and 3.9% for Rodent QC3 at the range
16.4–30.4 ng/mL.
Meiotic competence of oocytes from encapsulated
follicles grown in culture
Following 14 days of culture, all surviving antral follicles
that reached a diameter of 250 μm or greater were re-
moved from the alginate beads by incubating for 10 min
with 50 μl of pre-warmed alginate lyase media (α-MEM
with10 IU/mL alginate lyase) [MP Biomedicals, Irvine,
CA, USA]. Individual follicles were aspirated from the
follicle culture plate and placed in 20 μl droplets of mat-
uration media (α-MEM supplemented with 10% fetal bo-
vine serum, 5 ng/mL epidermal growth factor, 1.5 IU/mL
human chorionic gonadotropin, and 10 mIU/mL FSH)
for 16–18 h. After incubation, the expanded cumulus
granulosa cells were removed from the oocytes by add-
ing 0.5 μl of 0.3% hyaluronidase to each droplet. Oocytes
were aspirated, and the remaining adherent granulosa
cells were removed mechanically by pipetting. Images
were taken at × 400 using light microscopy, and the folli-
cles were classified as a germinal vesicle (GV), MI, and
MII or degenerated based on their morphology.
Quantification of transzonal projections
To assess the extent of transzonal projections—mem-
braneous extensions from the granulosa cells of the
ovarian follicles to the oocyte through the zona pellucida
that facilitates exchange between the two cells—the folli-
cles encapsulated in 0.25% alginate with and without
ADSCs were cultured for 2 days. Following 2 days of
culture, the follicles were removed from the alginate
after a 20-min incubation in 50 μl of alginate lyase media
(α-MEM with 10 IU/mL alginate lyase). The follicles
were then aspirated and fixed with 4% paraformaldehyde
at room temperature for 1 h. The follicles were stained
overnight for F-actin (1:50 Molecular Probes, Invitrogen)
and DNA (Hoechst 33342; Invitrogen) at 4 °C on a plate
shaker. Using a Nikon A-1 microscope, a 10-μm Z stack
image was obtained for ten follicles, from each follicle
size category, encapsulated with and without ADSCs.
Using ImageJ, an intensity profile was created by draw-
ing four pixel lines in the zona pellucida surrounding
the oocyte. Background intensity was determined for
each individual follicle, and the frequency of TZPs was
determined by the number of peaks in the profile above
the background threshold.
Statistical analysis
Statistical analyses were performed using GraphPad Prism
7 (GraphPad Prism Software, La Jolla, CA, USA). For all
statistical analyses, a p value less than 0.05 was considered
significant. Specifically, survival data was analyzed using
the built-in Kaplan-Meier survival curve analysis.
One-way analysis of variance (ANOVA) was performed
for ADSC survival and maturation data. Two-way
ANOVA were performed for follicle growth and TZP
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counting data to account for the effect of culture time
and/or initial follicle sizes. Sidak’s multiple comparisons
test was sequentially performed where appropriate.
Hormone data was analyzed using one-way ANOVA with
repeated measures, followed by Tukey’s multiple compari-
son tests to determine significant changes of hormone
levels over time within each follicle group.
Results
ADSCs maintain their viability and stemness within the
hydrogel
Assessment of viability using LIVE/DEAD assay (Molecu-
lar Probes) revealed that the majority (between 75 and
95%) of ADSCs maintained their viability in the alginate
hydrogel system (Fig. 1a, b) and was not affected by the
presence of the follicles. Live cells reacted with the Calcein
AM and fluoresced green, while the dead cells stained red.
Only a small percentage of cells were dead following 14
days of culture, which demonstrated that the alginate sys-
tem implemented for the follicle culture supported stem
cell viability. When cultured at the bottom of the flask,
the ADSCs demonstrated a fibroblast-like morphology,
adhered to the bottom of the plastic flasks, and expanded
in monolayer culture (Fig. 1c), thus meeting the standards
set forth for human-derived adipose stem cells [42].
ADSCs encapsulated in alginate remained circular for the
duration of the culture (Fig. 1d). Successful induction of
ADSCs into adipogenic, osteogenic, and chondrogenic
lineages further confirmed the stemness of the cells
(Additional file 1: Figure S1A).
ADSCs continue to express mesenchymal cell-specific
surface markers after 4 days of culture encapsulated in
alginate
Flow cytometry analysis of the cells after 1 and 4 days of
cell culture confirmed that the cells expressed SCA1,
CD34 (a surrogate marker for hematopoietic stem and
progenitor cells), and CD44 (a cell surface glycoprotein
involved in cell-cell interactions, cell adhesion, and mi-
gration), but were negative for CD45 (hematopoietic
marker) and CD31 (endothelial marker) (Additional file 1:
Figure S1B; day 0 and day 4 of culture). The fact that
these cells continue to express mesenchymal stem
cell-specific antigens after 4 days of culture in the algin-
ate bead indicates that they met (1) the minimum cri-
teria set forth by the International Society for Cell
Therapy for mesenchymal stem cells upon purchase and
(2) continue to demonstrate the phenotypic expression
of stem cells during the gonadotropin-independent stage
of early folliculogenesis.
Co-encapsulation of primary and early secondary follicles
with ADSCs improves in vitro follicular growth and
development
After isolation, based on the average initial diameters of
the follicles on day 0, the follicles were grouped into
three classes, small (85–95 μm), medium (96–105 μm),
and large (106–115 μm) (Fig. 2a–c). The follicles in the
85–95-μm range represented primary follicles character-
ized by an oocyte surrounded by a single layer of granu-
losa cells. The follicles in the 96–105-μm range had 1–2
Fig. 1 Encapsulation of ADSC in alginate. a Representative live/dead images of ADSCs in alginate over 14 days of culture in follicle culture conditions.
Scale bars = 500 μm. b No significant difference was found in ADSC survival in when compared to traditional two-dimensional culture over the 14-day
culture period. Sample size, n = 3. c Representative image of ADSC cultured in traditional tissue culture-treated flask. Scale bars = 100 μm.
d Representative image of ADSC cultured in alginate. Scale bars = 100 μm
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layers of granulosa cells. The follicles in the 106–
115-μm range had > 2 layers of granulosa cells. The
average starting follicle diameter for the three groups
ranged between 90 + 3.15 μm, 100 + 2.75 μm, and 110 +
2.64 μm. The typical growth pattern and antrum forma-
tion of the primary ovarian follicle co-encapsulated with
ADSCs in an alginate bead is demonstrated in Figs. 2d,
e. The follicles that did not grow and reach antral stages
usually extruded their oocyte (Fig. 2g) or had an abnor-
mal phenotype without the clear separation of the oo-
cyte from the granulosa cells (Fig. 2h). In some cases,
the follicles continued to grow without the presence of a
viable oocyte (Fig. 2i).
Initial studies focused on optimizing the number of
ADSCs for encapsulation with the follicles. Co-encapsu-
lation with 1.0 × 105, 3.0 × 105, 5.0 × 105, and 8.0 × 105
ADSC/mL showed marked improvement in follicle sur-
vival, although survival rate differed between the four
concentrations (Additional file 2: Figure S2 A, C, E).
Co-encapsulation of the follicles in all sizes with ADSCs
at a concentration of 1.0 × 105 did not contribute to im-
proved survival, while 3.0 × 105, 5.0 × 105, and 8.0 × 105
were better than 1.0 × 105 at least in one or more ranges.
Although optimal survival of the follicles in the range of
95–105 μm and 105–114 μm was achieved when they
were co-encapsulated with 8.0 × 105 cells/mL, primary fol-
licles with diameters ranging between 85 and 95 μm dem-
onstrated best survival (50%) when co-cultured with 5.0 ×
105 cells/mL for 14 days (Additional file 2: Figure S2A).
Since the concentration of 5.0 × 105 cells/mL maximized
the survival of the follicles in the 85 and 95-μm primary
follicle range and demonstrated improved survival across
the board, it was identified as the concentration for
co-encapsulation of ADSCs for further experiments and
used for all subsequent studies.
Survival rates of the follicles co-encapsulated with
5.0 × 105 ADSC/mL were significantly greater for all
three follicle size classes when compared with the fol-
licles cultured alone (p < 0.0001). The survival rate of
the follicles co-encapsulated with 5.0 × 105 ADSCs/mL
following the 14-day culture was 42.4% for the follicles
in the initial diameter range of 85–95 μm, 73.8% for
the 96–105-μm-diameter range, and 86.2% for the
106–115-μm-diameter range (Fig. 3, left panels). Only
5, 5.9, and 21.4% of the follicles of size classes 85–95,
96–105, and 106–115 μm survived when cultured in
the absence of ADSCs. Significantly fewer follicles in
the small (85–95 μm) diameter range survived, even
after co-encapsulation with ADSCs, compared to the
medium (96–105 μm, p = 0.0002) and the large (106–
Fig. 2 Representative images of the follicles in culture. Arrows = individual ADSCs in alginate. a–c Representative images of the follicles in vitro
from the three diameter groups (A = 85–95 μm, B = 96–105 μm, C = 106–115 μm). Scale bars = 50 μm (100 μm for inserts). d–f Representative
images of follicle growth and follicle development on days 2 (d), 4 (e), and 12 (f). Scale bars = 100 μm. g–i Representative images of various
modes of follicular death in vitro. g Extruded oocyte. h An atretic-looking follicle. i A dark and dense looking follicle. Scale bars = 100 μm
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115 μm, p < 0.0001) diameter groups. The survival rate
of the medium and the large diameter follicle groups
did not differ from each other (p = 0.0812).
All tested concentrations of ADSCs supported follicu-
lar growth to a greater extent compared to those cul-
tured in the absence of ADSCs (Additional file 2: Figure
S2 B, D, F). Following the 14-day culture of the follicles
co-encapsulated with 5.0 × 105 cells/mL, which was the
optimal cell number chosen, there was a statistically sig-
nificant improvement in follicular growth on culture day
14 for co-encapsulated follicles of an initial diameter of
85–95 μm (p = 0.0165) (Fig. 3, right panels). In
co-encapsulated follicles of initial diameter 96–105 μm,
there was a statistically significant increase in the follicle
size starting on culture day 10 (p = 0.0055), which con-
tinued through culture days 12 (p = 0.0063) and day 14
(p < 0.0001). Co-encapsulated follicles of the largest ini-
tial follicle size, 106–115 μm, reached the larger size, as
early as culture day 6 (p = 0.0007), which continued for
the duration of culture (p < 0.0001 for days 8 to 14). The
Fig. 3 Survival and growth of the follicles with and without co-encapsulation with ADSCs. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. Survival
and growth of the follicles in the ranges of 85–95 μm (a, b), 96–105 μm (c, d), and 106–115 μm (e, f) cultured alone (gray) or co-encapsulated with
ADSCs (black). Sample sizes of growth curves: 85–95 μm: n = 2 (follicle alone) and 25 (co-encapsulated); 96–105 μm: n = 5 (follicle alone) and 59
(co-encapsulated); and 106–115 μm: n = 9 (follicle alone) and 50 (co-encapsulated). Data in growth curves presented as mean ± SEM
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final follicular sizes of the follicles co-cultured with
5.0 × 105 ADSCs/mL were 273.6 ± 12.7 for the 85–95 μm,
334.3 ± 7.3 for the 96–105 μm, and 358.2 ± 8.9 for the
106–115-μm follicle classes, which were all significantly
greater than those cultured in the absence of ADSC.
Steroidogeneic potential of the follicles encapsulated
with ADSCs
As the functional unit of the ovary, the follicles are essen-
tial not only for their reproductive capabilities, but also
for their endocrine function as well. The steroid produc-
tion by the follicles co-cultured with ADSCs was used as
an index to confirm that the follicles perform their ste-
roidogenic role. The follicles cultured alone without
ADSCs did not survive in sufficient numbers to analyze
their steroidogenic activity for the whole duration of the
culture. Levels of A4 in all the conditions, 85–95 μm,
96–105 μm, and 106–115 μm co-encapsulated with
ADSCs, showed a progressive increase with time in
culture with levels on D14 significantly greater in the
106–115 group compared to D6 (p = 0.0300) and D8
(p = 0.0201) (Fig. 4, top row). Across all follicular
classes, A4 at all time points were significantly greater
than ADSCs cultured alone. Levels of E2 also showed
a progressive increase starting on day 8 and reaching
maximum concentration on day 14 for all three fol-
licular diameter classes. In the 85–95-μm follicular
group, D14 E2 levels were significantly higher than
that produced on D6 (p = 0.0287) and D8 (p = 0.0401).
In the 96–105-μm group, D14 E2 levels were signifi-
cantly higher compared to D6 (p = 0.0450). The levels
of E2 in the 106–115-μm group were significantly higher
on D12 (p = 0.0435) and D14 (p = 0.0346) of culture com-
pared to the D6 group (Fig. 4, second row).
Levels of P4 levels, similar to A4 and E2, also showed
an increase starting on day 8 (Fig. 4, bottom panel).
Levels of P4 on D14 of culture averaged 18.63, 30.68,
and 29.56 ng/ml respectively for the 85–95, 96–105, and
106–115-μm follicular groups. While P4 levels on D14
in the 85–95 μm follicular group was only significantly
higher than that of D6, the D14 levels in the 96–105 and
106–115-μm follicular groups were significantly higher
than seen on D6, D8, and D10 (Fig. 4, 3rd row).
The production of sex hormones A4, E2 and P4 by the
ADSCs were close to detection limit compared to the
levels secreted by the follicles and remained so for the
duration of the culture (Fig. 4, bottom row).
The androgen/estrogen ratio used to assess aromatase
(CYP19a1) activity [43–45] was 0.48, 0.38, and 0.29, re-
spectively, for the small, medium, and large follicle
groups (Fig. 4). A4/E2 ratio below or close to 1 suggests
appropriate quantities of steroid biosynthesis. Increase
in androgen/estrogen ratio would indicate an androgenic
intra-follicular milieu and less favorable environment for
follicle development and oocyte maturation, while low
ratios indicate appropriate interactions between theca
and granulosa cells that results in the conversion of A4
to E2.
Oocytes from the follicles co-cultured with ADSCs are
meiotically competent
In vivo, in response to LH, oocytes resume the meiotic
process and undergo germinal vesicle breakdown, and
progress through metaphase 1 (MI) and metaphase 2
(MII) stages (Table 1). Morphologically, the progression
from MI to MII is determined when meiotically compe-
tent oocytes extrude the polar body and resume meiosis
[28, 46]. The follicles co-encapsulated with ADSCs were
able to resume meiosis and undergo in vitro maturation.
A representative example is shown in Fig. 5. In vitro
maturation rate of the antral follicles in the 85–95-μm
group was 87.5%, in the 96–105-μm group was 93%, and
in the 106–115-μm group was 95%. None of the follicles
from all three classes when cultured without the ADSCs
were able to resume meiosis. This finding suggests that
the follicles co-cultured with ADSCs were able to pro-
duce meiotically competent oocytes.
Co-encapsulation with ADSCs is associated with an
increased number of transzonal projections
Transzonal projections (TZPs) are actin-rich, filament-
ous, cellular extensions that project from the granulosa
cell, transverse the zona pellucida, and terminate on the
oocyte cell surface (Fig. 6) [46, 47]. Hornick et al. have
found that TZP measurements taken on day 2 of the fol-
licle culture are predictive of follicle integrity [31]. They
reported that the follicles cultured individually had less
transzonal projections than the follicles co-cultured in
groups and decreased numbers of TZPs were associated
with decreased follicle survival and oocyte quality. Con-
sistent with this report, in our studies, the follicles from
all three size classes co-encapsulated with ADSCs had a
significantly higher number of TZPs between the oocyte
and cumulus granulosa cells relative to those not
co-cultured with ADSCs (Table 2).
Discussion
Findings from these studies indicate that
co-encapsulation of the follicles with ADSCs promotes
follicular survival, growth, and steroidogenesis. The
beneficial effects of ADSCs in promoting early follicular
growth and function are discussed below.
Prior studies have examined and established that
early-stage ovarian follicles undergo significant atresia,
and although activated, do not grow when cultured indi-
vidually [31–33]. Co-culture of early-stage follicles with
“feeder cells,” such as embryonic fibroblasts,
stromal-thecal cells, or mesenchymal stem cells, have
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been proposed to improve the outcomes of in vitro folli-
culogenesis. Yet, each of these previously established
“feeder cell” introduces certain limitations making them
less attractive for follicle culture especially in the context
of human translation. For example, co-culture with em-
bryonic fibroblast would necessitate the use of cells from
an allogeneic or xenogeneic source. The use of
stromal-thecal cells as the source from the frozen
ovarian tissue presents challenges, because of the quality
and purity of the cells. Some promise was demonstrated
with human mesenchymal cells derived from the bone
marrow that have been co-cultured with early-stage hu-
man follicles [42]. However, because the follicles were
cultured in groups and not grown to the antral stage,
the potential benefit of this approach relative to the ap-
proach used in our study cannot be ascertained. To
Fig. 4 Hormone secretion profiles of the follicles co-encapsulated with ADSCs and ADSCs only. Increasing hormone production during culture
suggests follicular function. Top row demonstrates the levels of A4, second row E2, and third row P4. Statistical significance was marked by
different letters. The hormone secretion profiles of ADSCs when encapsulated alone in alginate are demonstrated in the figure on the bottom
left. Sample size: n = 3 per follicle size group. Data presented as mean ± SEM. A4/E2 ratios on the last day of culture are summarized in the table
Table 1 Quantification of follicular in vitro maturation
Initial follicle size (μm) Follicles, n MII, n (%) MI, n (%) GV, n (%) DG, n (%)
85–95 24 11 (46) 10 (42) 1 (4) 2 (8)
96–105 55 29 (53) 21 (38) 1 (2) 4 (7)
106–115 36 18 (50) 16 (44) 0 (0) 2 (6)
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improve the outcomes of the primary follicle culture, the
use of ADSCs present a preferable tissue because they
can be obtained from the same donor as the ovarian tis-
sue, tissue acquisition is less invasive compared to
MSCs, and the cells can be harvested in larger amounts
when compared to other stem cell sources, such as the
bone marrow [48].
While the entirety of the beneficial secretome remains
unknown, ADSCs have been shown to secrete factors
important for follicular development such as HGF (hep-
atocyte growth factor), VEGF (vascular endothelial
growth factor), PGF (placental growth factor), TGF-β
(transforming growth factor-beta), LIF (leukocyte inhi-
biting factor), and IGF (insulin-like growth factor) [35,
49, 50]. The addition of these factors alone has not sup-
ported folliculogenesis in vitro, possibly because of the
dynamic bidirectional interactions between the follicles
and the ADSCs that cannot be replicated by adding spe-
cific components exogenously to the culture well. The
common link in the secretome and temporal signature
of these different paracrine secreting cells may hold the
answer to this question requiring a co-culture system for
provision of a full repertoire of paracrine factors. These
findings from this study that co-encapsulation with
ADSCs provided better support for follicle survival, im-
proved follicle growth and function relative to the folli-
cles cultured alone, are consistent with this premise.
Our finding that optimal outcome was not achieved with
low and high (> 500,000cells/mL) concentrations of
ADSCs point to the need not only for appropriate para-
crine factors but also for appropriate levels of paracrine
factors.
Co-encapsulation and co-culture of ADSCs contrib-
uted to successful oocyte maturation at the end of
Fig. 5 Representative images of oocyte stages after in vitro follicle maturation. GV germinal vesicle in an immature oocyte, GVBD germinal vesicle
breakdown, MII oocytes arrested at meiosis II stage
Fig. 6 TZP counts in the follicles cultured alone and co-encapsulated with ADSCs. Significantly higher numbers of TZPs are found between the
oocyte and cumulus granulosa cells of the follicles co-encapsulated compared to control after 2 days of culture. Scale bars = 10 μm. Sample size:
n = 10 per follicle size group per condition
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14-day long folliculogenesis that is evidenced by the fact
that oocytes cultured within our system were able to re-
sume meiosis, with > 90% of antrum forming follicles
undergoing germinal vesicle breakdown, and 40–55% ex-
truding the first polar body and entering into the second
stage of meiosis. Our results are similar to previously re-
ported studies in early-stage follicles [31–33] but lower
than the rates seen for secondary follicles [16, 51]. Simi-
lar to previous findings [31], the addition of a paracrine
secreting source (ADSCs in our study) increased the
number of TZPs. TZPs are vital for the communication
of the oocyte to its surrounding environment, exchange
of low molecular weight molecules, metabolic cooper-
ation between cumulus cells and oocytes, and regulation
of meiosis [51]. Increased number of TZPs in the ADSCs
co-encapsulated follicles suggests that co-encapsulation
with ADSCs sustains follicular integrity and is beneficial
for granulosa cell development as well as maintenance
of the critical communication between the oocyte and
its surrounding environment.
The findings from this study substantiate that
adipose-derived stem cells can act as “feeder cells”
within an in vitro culture system to provide the neces-
sary paracrine support for folliculogenesis, thus contrib-
uting to the function and survival of granulosa and theca
cells. This is also evidenced by our finding that the folli-
cles co-encapsulated with ADSCs produced and secreted
sex hormones similar to in vivo follicles [44, 45]. Ovar-
ian follicles co-encapsulated with ADSCs secreted ster-
oid hormones, which linearly increased with time in
culture and progression of follicle growth and differenti-
ation. Given that granulosa cells are incapable of directly
producing estradiol de novo, but require androgen sub-
strate derived from the theca cells, the successful pro-
duction of A4 in our co-encapsulation system proves the
presence and functional competency of theca cells,
which not only serves as a substrate for E2 production
but also for causing folliculotropic effects. The presence
of measurable E2 in our system also provides evidence
in support of successful bidirectional cross-talk between
the theca and granulosa cells. Compared to steroid hor-
mone production of murine follicles in alginate culture
[16, 24], co-encapsulation with ADSCs appears to pro-
duce higher levels of A4 and markedly higher levels of
P4 albeit similar levels of E2. In previously published
reports of murine steroid production, P4 levels were typ-
ically less than 1 ng/ml and P4/E2 ratios of < 0.5 were
representatives of normal physiologic ovarian function
[34, 43, 51]. Importantly, the lower A4/E2 ratios in the
larger follicles attest to the healthy status of the follicles,
which is matched with improved outcomes of folliculo-
genesis, survival, and growth.
Conclusion
Co-encapsulation of early-stage murine follicles with
ADSCs supports the in vitro maturation of murine folli-
cles. These in vitro matured follicles achieve meiotic
competence and display similar morphologic and ste-
roidogenic characteristics when compared to in vivo fol-
licles. To our knowledge, this is the first report of the
application of mouse ADSCs to support in vitro ovarian
follicular development in a 3D co-culture setting. Re-
search in this direction could provide the basis for future
research into the secretome of ADSCs within in vitro
culture system to help us better understand
ADSC-derived secretory factors that play vital roles in
establishing optimal ovarian micro-environment for pro-
moting early stages of folliculogenesis. Although the
scaffolding system used worked well for murine follicles,
future research should also be directed at biomaterials
that will allow the translation of these findings into hu-
man models. Approaches detailed in this study serves as
another step toward to goal of developing fertility pres-
ervation options for pre-pubertal girls with hematologic
malignancies.
Additional files
Additional file 1: Figure S1. The stemness and its maintenance of
ADSCs in 3D culture. A. Representative images of ADSC differentiation
(scale bars = 100 μm for osteogenic and adipogenic, and scale bar =
500 μm for chondrogenic). Data presented as mean ± SEM when
applicable. B. Representative images of histograms that showed positive
and negative expression of mesenchymal specific stem cell markers at
day 0 and after 4 days of culture. (TIF 7014 kb)
Additional file 2: Figure S2. Follicle survival and growth at various ADSC
concentrations. There is a significant survival rate improvement for the follicles
with an initial diameter of 85–95 μm at a concentration of 5.0 × 10 ^6 cells/ml.
Data presented as mean ± SEM in growth curves. (TIF 3046 kb)
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